Skip to content

Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy

A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03055676
Enrollment
319
Registered
2017-02-16
Start date
2017-01-31
Completion date
2020-04-30
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drainage, Pancreaticoduodenectomy

Keywords

Pancreaticoduodenectomy, Time of drain removal

Brief summary

The aim of this randomized prospective multicenter study is to demonstrate the hypothesis that early removal of drain could reduce the incidence of major complications (grade 2-4) after pancreaticoduodenectomy (PD) , when compared with later removal of drain.

Detailed description

The objective of this randomized prospective multicenter study is to investigate the association between the time of removal of drain after pancreaticoduodenectomy (PD) and incidence of major complications (grade 2-4 complications). The investigators unite six pancreatic surgery center in Beijing. Patients who underwent pancreaticoduodenectomy (PD) or pylorus-preserving pancreaticoduodenectomy (PPPD) with low to moderate risk of post-operative pancreatic fistula (POPF) are recruited into the study. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 5 or beyond. The primary outcomes are the incidence of sum of grade 2-4 complications, the secondary outcomes include grade B/C POPF, intra-abdominal infeciton, delayed gastric emptying, post-operative bleeding, in-hospital stay, total medical cost and comprehensive complication index (CCI).

Interventions

Removing drain(s) on postoperative day 3

Removing drain(s) on postoperative day 5 or later

Sponsors

Peking University First Hospital
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Xuanwu Hospital, Beijing
CollaboratorOTHER
Beijing Chao Yang Hospital
CollaboratorOTHER
Beijing Tongren Hospital
CollaboratorOTHER
Chinese Academy of Medical Sciences
CollaboratorOTHER
Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. PD with or without pylorus preserving; 2. Age between 18 and 75 years; 3. Drain amylase on POD 1 and 3 less than 5000 U/L; 4. Drain output within POD 3 less than 300 ml per day.

Exclusion criteria

1. Vascular reconstruction using an artificial graft; 2. Grade B/ C postoperative bleeding, evident anastomosis leakage within 3 days after surgery; 3. Refusale to participate in after signed informed consent.

Design outcomes

Primary

MeasureTime frameDescription
The sum of grade 2- 4 complicationsUp to postoperative 90 daysThe severity of complication was measured by Clavein Dindo classifications and grade 2- 4 complications always affect the recovery of the patients significantly.However, the death case (grade 5 complication) is rare now for PD in high volume centers. According to our single center study, early drain removal could reduce the rate of grade 2-4 complications by 12% for the patients undergoing major pancreatectomy.

Secondary

MeasureTime frameDescription
Delayed gastric emptyingUp to postoperative 90 daysThe International Study Group of Pancreatic Surgery (ISGPS) definition: Inability to return to a standard diet by the end of the first postoperative week with prolonged nasogastric intubation.
Grade B/C complicationsUp to postoperative 90 daysThe International Study Group of Pancreatic Surgery (ISGPS) definition
Length of hospital stay (day)Up to postoperative 90 daysParticipants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Intra-abdominal bleedingUp to postoperative 90 daysThe International Study Group of Pancreatic Surgery (ISGPS) definition: Blood loss through abdominal drains or nasogastric tube;hematemesis or melena; clinical deterioration of the patient; unexplained hypotension or tachycardia; or laboratory findings such as a decreasing hemoglobin concentration.
Interventional treatmentUp to postoperative 90 daysinterventional treatment for any complication.
Total medical expensesUp to postoperative 90 daysTotal medical expenses during hospitalization.
Any other single intem of grade 2-4 complicationUp to postoperative 90 daysClavein Dindo Classification is adopted.
Comprehensive complication index (CCI)Up to postoperative 90 daysintegrates all complications of the Clavien-Dindo classification (CDC) and offers a metric approach to measure morbidity.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026